Artia Global Partners »

Boston Scientific Corporation shares owned by Artia Global Partners

Quarter-by-quarter ownership of Boston Scientific Corporation (BSX) shares owned by Artia Global Partners from 13F filings

Historical chart of Artia Global Partners investment in Boston Scientific Corporation

Tip: Access up to 7 years of quarterly data

All positions including Boston Scientific Corporation held by Artia Global Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Boston Scientific Corporation by Artia Global Partners

Quarter filed Position value Share count Share price at filing
2025-09-30 $18M 183k 97.63
2025-06-30 $17M 155k 107.41
2025-03-31 $13M 130k 100.88

More positions owned by Artia Global Partners

Insmed Com Par $.01 (INSM)
Argenx Se Sponsored Adr (ARGX)
Soleno Therapeutics (SLNO)
Verona Pharma Sponsored Ads (VRNA)
Uniqure Nv SHS (QURE)
Merus N V (MRUS)
Proshares Tr Ii Ultra Gold (UGL)
Eli Lilly & Co. (LLY)
Vertex Pharmaceuticals Incorporated (VRTX)
Abivax Sa Sponsored Ads (ABVX)
Trevi Therapeutics (TRVI)
Boston Scientific Corporation (BSX)
Alnylam Pharmaceuticals (ALNY)
Quest Diagnostics Incorporated (DGX)
Astrazeneca Sponsored Adr (AZN)

View all positions for Artia Global Partners

Top funds holding Boston Scientific Corporation

BlackRock
Vanguard Group
FMR
State Street Corporation
PRIMECAP Management Company
Geode Capital Management
Jpmorgan Chase & Co
Capital World Investors
Morgan Stanley
Bollard
Invesco
Goldman Sachs Group
Wellington Management Company
Northern Trust
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main

View all funds holding Boston Scientific Corporation